RTW Biotech Opportunities (LSE:RTW) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is RTW Biotech Opportunities Change In Payables And Accrued Expense?

RTW Biotech Opportunities's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was $0.00 Mil. It means RTW Biotech Opportunities's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

RTW Biotech Opportunities's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was $0.00 Mil. It means RTW Biotech Opportunities's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

RTW Biotech Opportunities Change In Payables And Accrued Expense Historical Data

The historical data trend for RTW Biotech Opportunities's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RTW Biotech Opportunities Change In Payables And Accrued Expense Chart

RTW Biotech Opportunities Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

RTW Biotech Opportunities Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial							-	-	-	-	-

RTW Biotech Opportunities Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

RTW Biotech Opportunities Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of RTW Biotech Opportunities's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

RTW Biotech Opportunities Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » RTW Biotech Opportunities Ltd (LSE:RTW) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

St Julian’s Avenue, Royal Chambers, 1st Floor, Saint Peter Port, GGY, GY1 3JX

Website

https://www.rtwfunds.com/rtw-biotech-opportunities

RTW Biotech Opportunities Ltd is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. Its approach is driven by applying deep scientific expertise with a long-term investment horizon. Geographically, it operates in U.S. &Canada, UK & EU, and Rest of the world.

RTW Biotech Opportunities Headlines

No Headlines